Skip to content
Screener

AngioDynamics ANGO Med Device — Gross Margin %

Similar metrics at other companies

Artivion logo
AORTMedical devices — Total gross margin
$65.91M+11.5%
Axon Enterprise, Inc. logo
AXONConnected Devices — Adjusted gross margin
$270.34M+40.5%
Molina Healthcare logo
MOHService margin — Gross Profit
$2M-33.3%
Walmart logo
WMTGross margin
25%+0.1pp
Semtech logo
SMTCGross margin
51.6%+0.4pp
AutoZone logo
AZOGross margin
51.8%-1.2pp

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept ango:GrossMarginPercentage.

The source filing: AngioDynamics’s 10-Q, filed April 2, 2026.

Filed
Apr 2, 2026, 12:00 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-023008
(in thousands)Three Months Ended / Feb 28, 2026Three Months Ended / Feb 28, 2025Nine Months Ended / Feb 28, 2026Nine Months Ended / Feb 28, 2025
Med Device Net Sales$41,141$40,663125,371$121,477
Med Device Cost of Sales (exclusive of intangible amortization)22,95421,39465,75263,388
Gross Margin18,18719,26959,619$58,089
Gross Margin %44.2%47.4%47.6%47.8%
Total Net Sales$78,423$72,004$233,567$212,340
Total Cost of Sales (exclusive of intangible amortization)36,94433,147105,44896,853
Gross Margin41,47938,857128,119115,487
Gross Margin %52.9%54.0%54.9%54.4%

Item 1. Financial Statements.

FAQ

What is AngioDynamics's med device — gross margin %?
AngioDynamics (ANGO) reported med device — gross margin % of 44.2% in Q4 2025.
How has AngioDynamics's med device — gross margin % changed year-over-year?
AngioDynamics's med device — gross margin % decreased by 6.8% year-over-year, from 47.4% to 44.2%.
What does med device — gross margin % mean?
Gross margin percentage represents the proportion of net sales that remains after deducting the direct costs of goods sold for the medical device segment. It is a key measure of pricing power and manufacturing efficiency, indicating how much of every dollar earned is available to cover operating expenses. Higher margins generally suggest a competitive advantage in product pricing or superior cost management in the medical device market.

Ask your AI about AngioDynamics's med device — gross margin %.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude